Grant: Idea to Innovation
University of Toronto
$87,500.00
Artery-on-a-chip screening instrument
EF 2011-12
Résumé
We propose to develop an instrument for the routine screening of small blood vessels that is based on a technology that was developed with NSERC I2I Phase 1 funds. The Artery-on-a-Chip Screening Instrument is intended to penetrate the pressure myography market and further expand into organ-based drug screening. A Beta prototype will be developed with our partner Quorum Technologies and placed at six world-leading microvascular research laboratories and biotechnology companies.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
396250-2010
Name nom
Guenther, Axel
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
87500
Program id
I2IPJ
Program nane en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
2
Application title
Artery-on-a-chip screening instrument
Keyword
NSERC
Application summary
We propose to develop an instrument for the routine screening of small blood vessels that is based on a technology that was developed with NSERC I2I Phase 1 funds. The Artery-on-a-Chip Screening Instrument is intended to penetrate the pressure myography market and further expand into organ-based drug screening. A Beta prototype will be developed with our partner Quorum Technologies and placed at six world-leading microvascular research laboratories and biotechnology companies.